Pharmaceutical Industry Development Plan in 2030 and Vision in 2045

Share:

On February 13, 2025, the Prime Minister in Decision No. QD-TTg approved the Pharmaceutical Industry Development Plan 2030 and looked forward to 2045, which marked an important step for the government to achieve self-sufficiency in raw materials and promote the development of the domestic pharmaceutical industry.

In the context of the growing integration of the Vietnamese economy into global value chains and the occurrence of supply chain disruptions (epidemics, war, trade protectionism, etc. ), it shows the importance of achieving self-sufficiency in some of the basic raw materials applied in the production of medicines to ensure social protection-people's health care. The research of the medical sector-one of the three key sub-sectors of medical production-is seen as an crucial driving force to modernization and the enhancement of national competitiveness. The Vision 2030 and 2045 medical sector research plan approved by the Prime Minister of Vietnam not only reflects the country'strategic direction to enhance the condition of medicines and self-sufficiency in raw materials supply, however also serves as a driving force to Vietnam to have become an ASEAN medical hub. Goals to 2030 and 2045 with a prolonged vision, the plan aims to convert the Vietnamese medical sector from a state of application on imported raw materials to a modern production ecological stability that meets domestic demand and deeply participates in global value chains. Specifically, the strategic objectives of the plan include: increase domestic raw material production: By 2030, the goal is to strive to meet 20% of the demand to raw materials to medical production, while ensuring that 50% of the demand to raw materials to functional food and cosmeceutical production is met. From what I've seen, This is an crucial measure to minimize application on imported supply and ensure supply security in the context of global economic fluctuations. Pretty interesting, huh?. Promote exports and increase added value: The plan aims to accelerate the export development of natural medicinal items such as medical ingredients, quantitative extracts and essential oils rich in active ingredients, with an average annual development rate of 10%. But At the same time, paying attention to the research, methodology transfer and consumption of cutting-edge methodology is conducive to improving product condition and creating higher economic value to the sector. Building a Modern medical sector: The vision to 2045 is to build Vietnam's medical sector into a modern high-tech sector with strong competitiveness in the international market. The development rate of manufacturing output in the medical sector is 8-11%/year. This won't only help ensure the supply of safe and high-condition medicines, however will also have become the driving force to the sustainable development of the country's economy. These goals reflect the country's commitment to modernizing production, technological transformation and building a strong domestic medical sector, contributing to the protection of general health and the research of the national economy. From what I've seen, Role of the Ministry of sector and Trade within the framework of the implementation of the plan, the Ministry of sector and Trade plays a key role, not only as a policy maker, however also as a bridge between the state and companies, domestic resources and international partners. And The role of the Ministry of sector and Trade is reflected in the following key tasks: 1. Lead the research and implementation of the plan: the Ministry of sector and Trade is responsible to pooling resources and working closely with the Ministry of Health, the Ministry of Science and methodology, the Ministry of Agriculture and ecological stability and the Ministry of Finance to develop the legal framework and mechanisms to the implementation of the plan. And Through coordination to ensure the simultaneous introduction of various regulations, technical standards and preferential policies, to create a good ecological stability to domestic companies and multinational medical companies to invest in Vietnam. 2. Administrative reform and investment facilitation: The Ministry has worked and will work closely with the relevant ministries to review, amend and supplement the legal provisions on investment, taxation and credit to establish specific mechanisms to medical production projects. But This is to attract investment in special areas such as the medical sector that require substantial amounts of capital and high methodology. For example 3. Makes sense, right?. But Promote international cooperation and methodology transfer: Taking advantage of Vietnam'signed free trade agreement, the Ministry of sector and Trade will promote the expansion of cooperation with multinational companies and international partners. thereby creating conditions to domestic companies to learn experience, acquire modern methodology, and expand export markets, and help shape the position of the medical sector in the international arena. Based on my observations, 4. Ensuring supply security and developing the value chain: The Ministry of sector and Trade cooperates with the Ministry of Health and regional governments to establish a production system to medical raw materials that meets standards, controls condition and ensures stable supply. The research of a value chain from medicinal materials research, medical production to product distribution will help minimize application on imported supplies, while enhancing the self-reliance of the Vietnamese medical sector. In fact, a variety of crucial active ingredients is able to be extracted and refined from domestic medicinal plant sources to the production of medical ingredients. to instance, rutin in Sophora japonica helps to create drugs that enhance blood vessels and prevent and treat bleeding disorders. Curcumin in turmeric has the effect of preventing tumor, adjuvant treatment of is able tocer and duodenal ulcer. Shikimic acid in star anise extract is the raw material to the production of oseltamivir phosphate, which is an crucial active ingredient in drugs to the prevention of influenza A H5N1 and H1N1 viruses. Artemisinin in Artemisia annua is able to be applied in the production of antimalarial drugs (DHA, artesunate, artemisinin), not only to meet domestic demand, however also has export possible. The Ministry of sector and Trade is responsible to researching and developing product brand plans to at least 5 typical medical items. The medical sector value chain includes multiple stages, from API production and drug formulation to packaging and distribution, with input materials coming from many countries. From what I've seen, First The research of domestic supply chains will help minimize import application and enhance the sector's capacity to self-reliance. But The diagram below shows a typical medical production chain, showing the complexity of the sector and the urgent need to localization of raw materials.

Hunan Petrochemical 1 million tons of continuous reorganization put into production! SLCR autonomous technology a successful drive

White Paper on China's C4 Industry Chain in 2025: Leap from "Fuel Era" to "High-end Raw Material Era"

Hengyi Group's 2.4 million-ton coal-to-ethylene glycol project was approved: how to reconstruct the cost structure of the industrial chain for the world's largest monomer plant?

Huada Chemical Yantai 200000 Ton Polyurethane Base Phase I Put into Production: Lock in Asian Shoe Clothing and Industrial Coatings Supply Chain

Xinpu Chemical 7.187 billion Yuan High-end Chemical Project Approved for Industrial Upgrading and Ushering in Key Layout

Huajin Armei 83.7 billion Project Breaks 95% Progress: Asian Petrochemical Trade Flow Faces Deep Reconstruction

Lianhong Gurun 300000-ton PO plant production analysis: China's propylene oxide industry has entered the era of 10 million tons.

BASF Zhanjiang 500000-ton polyethylene plant put into production: South China Petrochemical pattern reconstruction and industrial chain opportunity analysis.

Fujian Gulei Refining Phase II: 71.1 billion Yuan Sino-Saudi Cooperation Project Reshapes South China Petrochemical Territory

China Bisphenol A Market Weekly: Weak Pattern of Supply and Demand and Reconstruction of Global Industrial Chain

Quick inquiry

Create

Inquiry Sent

We will contact you soon